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ABSTRACT
Objectives: This study is to investigate the effect of oral Vitamins combined (A, C, and E) with metformin on the levels of fasting blood sugar (FBS), 
postprandial blood sugar (PPBS), hemoglobin (HbA1c), total cholesterol (TC), triglycerides (TG), high-density lipoprotein (HDL), and low-density 
lipoprotein (LDL) in Type 2 diabetic patients.
Methods: A total of 32 patients with Type 2 diabetes were divided randomly into A and B groups, i.e., 16 per each group. Group A received metformin 
only twice a day while Group B received one tablet of Antox and metformin twice a day for 3 months. FBS, PPBS, HbA1c, TC, TG, LDL, and HDL were 
measured before and after the dose, and the results were analyzed statistically.
Results: A significant decreases in FBS, PPBS, HbA1c, TC, TG, and LDL whereas results showed increasing significance in HDL level that seen in the 
patients of Group B which received Antox and metformin compared to the group which received metformin only. In conclusion, the results indicate 
that daily consumption of supplementary vitamins with metformin leads to improving blood glucose and lipids in patients with Type 2 diabetes and 
reducing the risk of complications. Hence, the dose can be used combined Vitamins A, C, and E with metformin in the treatment of Type 2 diabetes by 
maintaining good glycemic control.
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INTRODUCTION
Diabetes mellitus is a group of metabolic disorders characterized 
by hyperglycemia resulting from disability in insulin action, insulin 
secretion, or both [1]. Recent studies indicate that 171 million people 
worldwide suffer from diabetes in 2000 and the number of people with 
diabetes is expected to rise to 366 million by 2030 [2,3].
An antioxidant is a molecule that inhibits the oxidation of other 
molecules, and a substance which slows down the damage that can be 
caused to other substances by the effects of oxygen. Food which contains 
antioxidants is thought to be very good for diabetes. However, later the 
biologists realized the significance of antioxidants in health that was 
in the 1960s publications of vitamins and flavonoids [4]. Usually, there 
are many antioxidants including A, C, and E. Vitamin C is an important 
antioxidant in a human which is capable of scavenging oxygen-derived 
free radicals [5]. A previous study has shown a decrease in basal Vitamin 
C level in Type 2 diabetes mellitus [6]. Another study indicated that 
daily consumption supplementary Vitamin C can be useful in reducing 
lipids and blood glucose in patients with Type 2 diabetes and therefore 
degrading the risk of complications [7]. Vitamins C and E are known 
for their beneficial effects on blood sugar, serum lipids, and glycated 
hemoglobin (HbA1c) [8]. In addition to its role as an antioxidant, 
studies have also shown the role of vitamin A in the upregulating the 
antioxidant enzyme functions in the body. In the study on obese mice, 
the results have shown that Vitamin A supplementation resulted in 
reducing hyperglycemia and hyperlipidemia [9].
This study was conducted to evaluate and to measure the effect of 
Vitamins A, C, and E supplemented along with metformin on levels 
of fasting blood sugar (FBS), postprandial blood sugar (PPBS), total 
cholesterol (TC), low- and high-density lipoprotein (LDL and HDL), 
triglycerides (TG), and levels of HbA1c in patients with Type 2 diabetes.
MATERIALS AND METHODS
A total of 32 patients with Type 2 diabetes mellitus participated, in the 
study which has continued for 3 months and the study was performed 
in accordance with the principles outlined in the Declaration of 
Helsinki has been approved by Dr. Babasaheb Ambedkar Marathwada 
University, Aurangabad, India, and the Ethics Committee at Halmeen 
Hospital, and AL-Amal Medical Diagnostic center Lahj, Yemen. All 
patients give their informed consent before their inclusion in the 
study. These are patients diagnosed with Type 2 diabetes of age group 
between 30 and 70 years who were dependent on metformin dose 
so that the treatment was used by having Glucovance, each tablet of 
Glucovance 500 mg/2.5 mg, contains 500 mg Metformin and 2.5 mg 
of glibenclamide, manufacturer Merck Sante s.a.s. 2, rue du pressoir 
Vert 45400 SEMOY- FRANCE. Patients who have fasting blood glucose 
level >300 mg/dl, medical illnesses including metabolic, type 1 diabetes, 
pregnancy, and age <30 years, and age >70 years were excluded from 
the study. None of the subjects was smoker, drinker or had been taking 
any psychotropic drug. Patients who have received Vitamins A, C, and 
E or any other antioxidant over the past 3 months were also excluded 
from the study. The period of the present study was from September 
2016 to February 2017.
Patients with Type 2 diabetes were divided randomly into two groups: 
A and B of 16 patients in each group. The sample size was calculated 
with the standard deviation taken from a study and the level of 
significance at ≤0.05. The drug was given to patients for the duration of 
1 month at a time. Patients were required to return the unused drugs 
and container during the follow-up treatment, so 95% consumption 
was considered to be suitable. Drugs were decoded at the end of a trial. 
Group B received Antox dose a dietary supplement produced by Arab 
company for pharmaceuticals and plant – Egypt with Metformin and 
Group A received metformin only. The dose Antox content on combined 
© 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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with Vitamins A, C, and E was given twice a day to Group B. At the same 
time, all patients received tablet metformin 500 mg twice daily orally 
with breakfast and dinner; similar, doses were kept throughout the 
study. If we found increased FBS level 300 mg/dl through the study 
time, then we excluded that patient from the study. No disease condition 
or infection happened to these study patients through the study period.
After the study performance was over, the subjects were given over to 
the specialist physician of diet; all patients were maintained on their 
normal dietary type while reducing their consumption of Vitamins 
A, C, and E rich food during the study. A patient was commanded by 
a physician to use a basic food list that contained food suitable for 
diabetic patients. Investigations of values were considered normal; 
FBS <126 mg/dl, TC <200 mg/dl, TG <160 mg/dl, HDL-cholesterol 
35–55 mg/dl, LDL- cholesterol <100 mg/dl, and HbA1c 6. Age and sex 
were examined and recorded. Blood samples were drawn before and 
after a meal from the patients to measure levels of FBS, PPBS, TC, LDL 
and HDL, TG, and glycated HbA1c. These were measured before the 
initiation of supplementation with Vitamins A, C, and E. Which have 
been used for doing these investigations, the following methods were 
used: Kit Spinreact.
• Estimation of serum glucose by Glucose oxidase–peroxidase method.
• Estimation of serum TC by cholesterol oxidase–peroxidase method.
• Estimation of serum TG by Glycerol-3-oxidase–peroxidase method.
• Estimation of serum HDL by cholesterol oxidase method.
• Estimation of serum LDL by Friedewald formula.
• Estimation of glycated HbA1c by SD A1cCare.™
After 3 months of supplementation with Vitamins A, C, and E, patients 
were examined again, and the tests were repeated.
Statistical analysis
Results were expressed as mean±standard deviation. Group differences 
were calculated by SPSS paired t-test. Two-tailed p value was used 
throughout the analysis, and the p values which were ≤0.05 were judged 
statistically significant (p≤0.05). IBM SPSS statistical (version 21) was 
used.
RESULTS
The mean age of the patients with diabetes mellitus in control group 
was 49.06+10.70 years and experimental group 48.68+11.47 years; 
it was not significantly different from each other (Table 1). Fasting, 
postprandial blood glucose, HbA1c, TC, TG, HDL, and LDL did not differ 
among subjects before treatment in the control group and experimental 
group (p≤0.05).
In the control group, levels of FBS reduced significantly (p≤0.05). 
PPBS also reduced but did not reach the level of statistical significance 
(p≤0.05). At the same time, levels of HbA1c had no improvement after 
3 months of treatment compared to pre-treatment levels. Increasing 
the level of lipid profile was seen, and it was not a statistically 
significant level of reduction in HDL so that there was no improvement 
(Table 2). In the experimental group, reduction in FBS from 192.13 to 
158.94 p=0.000, PPBS from 268.50 to 231.75 p=0.000, HbA1c from 
9.48 to 8.23 p=0.000, TC from 177.56 to 165.50 p=0.001, TG from 
168.56 to 157.88 p=0.048, and LDL from 104.69 to 90.56 p=0.000 were 
significant, and at the same time level of HDL reached to statistically 
significant p=0.000, where it increased from 39.56 to 44.06) (Table 3).
To test whether oral supplementation of Antox containing Vitamins A, 
C, and E is better in reducing level fasting blood glucose, postprandial 
blood glucose, glycosylated hemoglobin, TC, TG, and LDL as compared 
to control group, in comparing the effects of medication metformin 
in control group and metformin with Antox in experimental group 
after 3 months of conducting the treatment, taking into concern the 
change from baseline values of these parameters. Decrease in fasting, 
postprandial blood glucose, and glycosylated hemoglobin level were 
significant after 3 months in the experimental group compared to the 
control group. In contrast, plasma HDL increased significantly in the 
experimental group compared to the control group. At the same time, 
lipid profile (TC, TG, and LDL) levels decreased significantly in the 
experimental.
In the course of the trial, no serious adverse effect was reported, and 
no abnormalities in laboratory test were found during the study period.
DISCUSSION
Showed present study  a significant decrease  in  level FBG, PPBG, HbA1c, 
TC, TG, and LDL and an increase in HDL level the diabetes patients which 
reached to the significance level after the treatment by use (Antox) 
supplementation along with metformin in patients of type 2 diabetes. To 
my knowledge of experience, this is the first report related to a significant 
improvement in all the above parameters after concomitant use of Antox 
(Vitamins A, C, and E) with metformin. The results of this study are in 
agreement with previously published data showing improvement in 
glycemic control with Vitamin supplementation A or C or E or together. 
In this study, patients received metformin which is an established first-
line drug for the treatment of Type 2 diabetes. Hence, it is difficult to say 
whether this beneficial effect of Antox supplement could be related to its 
effect on the underlying disease or correction of the inadequate Vitamins 
A, C, and E status, but it showed a beneficial effect in the group which 
used Vitamins A, C, and E (Antox) with metformin better than the second 
group which used only metformin. It is well known from previous studies 
that there is an increased production of damaging free radicals in Type 2 
Table 1: Age and distribution
Variables Age Male Female
Group A 49.06±10.70 8 8
Group B 48.68±11.47 8 8
Values are given as Mean+SD, 32 all groups, Group A: Control group, 
Group B: Experimental group
Table 2: Group A control the effect of metformin only on FBS, 
PPBS, HbA1c, TC, TG, HDL, and LDL in patients with type 2 
diabetes after 3 months of treatment
Parameter Before treatment After treatment p
FBS 184.06±49.03 174.13±46.60 0.029
PPBS 257.94±46.74 248.63±49.82 0.085
HbA1c 8.98±1.59 8.99±1.48 0.926
TC 174.38±36.91 178.56±44.76 0.345
TG 164.56±63.19 178.25±65.42 0.159
HDL 42.44±7.23 40.56±9.32 0.090
LDL 99.19±39.59 102.13±44.59 0.431
n=16 in number, FBS: Fasting blood sugar, PPBS: Postprandial blood sugar, 
HbA1c: Glycosylated hemoglobin, TC: Total cholesterol, TG: Triglyceride, 
HDL: High-density lipoprotein, LDL: Low-density lipoprotein, are measured 
in mg/dl
Table 3: Group B, experimental, effect of metformin with Antox 
(A, C, and E) on FBS, PPBS, HbA1c, TC, TG, HDL, and LDL in 
patients with type 2 diabetes after 3 months of treatment
Parameter Before treatment After treatment p
FBS 192.13±38.91 158.94±27.16 0.000
PPBS 268.50±39.86 231.75±38.55 0.000
HbA1c 9.48±0.99 8.23±0.97 0.000
TC 177.56±49.28 165.50±48.34 0.001
TG 168.56±55.47 157.88±50.58 0.048
HDL 39.56±4.80 44.06±3.82 0.000
LDL 104.69±49.24 90.56±49.59 0.000
n=16 in number, FBS: Fasting blood sugar, PPBS: Postprandial blood sugar, 
HbA1c: Glycosylated hemoglobin, TC: Total cholesterol, TG: Triglyceride, 
HDL: High-density lipoprotein, LDL: Low-density lipoprotein, are measured 
in mg/dl
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diabetes patients. Glucose auto-oxidation, protein glycosylation, in a 
formation of the polyol pathway, and advanced glycation end products are 
involved in the generation of oxidative stress, which involved in the origin 
of both Type 1 and 2 diabetes [10]. The imbalance between the reactive 
types and the antioxidants leads to the production of oxidative stress 
which causes the development of the condition to diabetes. There are 
beneficial effects of antioxidant on the complications of diabetes in which 
reduce oxidative stress and relieve diabetes and its complications [11,12].
The protection against damage can be provided free radical-scavenging 
by antioxidants. The first important observation of the studies was a 
significant reduction in FBS, PPBS, HbA1c, TC, TG, and LDL in varying 
periods of time when adding Vitamins (A, C, and E) to the experimental 
groups either combined or single. In previous studies, combined doses 
(500 mg/day twice) for 4 months, of Vitamins E and C in addition to 
the normal food improved the plasma glucose (FBS) and lipid profile 
in patients with Type 2 diabetes [8]. Another study reported that the 
kidney function of diabetic animals can be improved. In a trial including 
supplementation with combined Vitamins C and E that group given 
the antioxidants had a significantly less concentration of urinary 
microalbumin secretion in comparison to the control group [12].
Supplementation of Vitamin C significantly reduced FBG and HbA1c 
levels in Type 2 diabetic patients. In the previous study, supplementation 
with 500 mg/day Vitamin C in diabetic patients no changes in FBG and 
HbA1c in comparison with placebo this may be related to revealed a low 
dose of Vitamin C [13]. An earlier study confirmed on Type 2 diabetes 
patients, that daily consumption 1000 mg supplementary Vitamin C 
can be useful in significantly reducing glucose and lipids in patients 
with Type 2 diabetes and hence reducing the risk of complications [7]. 
The study proposed that supplementation of Vitamin C significantly 
reduces FBS, PPBG, and HbA1c (good glycemic control) [14]. Another 
study indicating that after treatment with Vitamin C along with 
metformin compared to placebo with metformin, FBS, PPBS, and HbA1c 
levels showed a significant improvement after 12 weeks of treatment 
with Vitamin C [15]. Another study showed that there is a significant 
decrease in levels of serum LDL and HbA1c in the patients who received 
supplementation 1000 mg/day of Vitamin C during 6 weeks [16]. In 
another study, an improvement appeared in a decrease of TC using 2 g 
of Vitamin C for 90 days [17].
Vitamin E improves results which are correlated with pancreas 
physiology in diabetes which may improve functional results of 
diabetes [18]. In a study carried out to evaluate the ability of oral 
supplementation of Vitamin E (900 mg\day) in Type 2 diabetes 
patients over 4 months period, it was shown that the supplementation 
of Vitamin E decreased insulin resistance and improved glucose 
uptake [19]. As revealed in another study that supplementation of 
100 IU of Vitamin E could reduce the HbA1c levels in type 1 diabetic 
patients [20]. Some studies have also shown that Vitamin E can be a 
helpful addition to decreasing oxidative stress in Type 2 diabetes. 
This was confirmed by a previous study in which HbA1c and other 
proteins were reduced with each 600 or 1200 mg/day of Vitamin E 
for 2 months [21]. The previous studies have shown that Vitamin E is 
helpful in leading significantly reducing approximately 60% of plasma 
LDL oxidation in diabetic patients [18]. As shown in another study, 
it is significantly reducing cardiovascular effects in people with 
diabetes [22].
It has been observed that the Asian developing countries and the lower 
poorer groups in the United States where diabetes is on the increase 
have a deficient Vitamin A status [23]. An increased concentration of 
both cellular retinoic acid binding protein and cellular retinol binding 
protein in the islets results from a deficiency of Vitamin A and may 
reduce insulin release. Retinoic acid has been recently identified as 
a regenerator of rat insulinoma cell line. It is also reported to raise 
glucokinase activity in RINmF5 cell line as well as fetal islets and 
differentiated adult islets boasting of a role in the regulation of islet 
function and insulin release [24]. Furthermore, retinoid biology has 
vital importance in diabetes progression. Both too little retinol and 
an excess of it can have harmful effects on disease onset. A bond has 
been found between diabetes and deficient Vitamin A levels indicating 
Vitamin A supplementation have a role in Type 2 diabetes biology [25].
According to previous findings, single vitamin and a low single dose 
in the same time did not cause significant benefits in all cases and 
all parametric (glucose and lipid profile) in diabetes patients, but 
increased dose causes significant benefits. In the present study, 
combined Vitamins A, C, and E (ANTOX) twice daily for 3 months 
caused a significant decrease in FBG, PPBG, HbA1c, TC, TG, and LDL 
and an increasingly significant in HDL level after treatment by Antox 
supplementation along with metformin in patients of type 2 diabetes 
(Fig. 1).
CONCLUSION
Treatment with Antox (combined Vitamins A, C, and E) twice daily with 
metformin for 3 months period was well tolerated and devoid of any 
side effects. This treatment has not any substantial side effects. It has 
led to improvement in that it caused a decrease FBG, PPBG, HbA1c, TC, 
TG, and LDL and an increasingly significant in HDL level after treatment 
for the Type 2 diabetes which makes it a therapy useful therapeutic in 
the treatment and improvement of Type 2 diabetic patients.
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